05/15/2025
3:38 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
3:41 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
2:33 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
9:44 AM | Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
8:09 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:08 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
6:15 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
4:44 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SCHEDULE 13G/A | |
04/02/2025
7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
04/02/2025
7:06 AM | Charles River Laboratories International (Filer)
| Form ARS | |
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. |
02/26/2025
3:18 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:36 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:38 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:41 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
11:36 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
8:07 AM | Charles River Laboratories International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
6:19 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
4:17 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:22 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:25 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:27 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
7:04 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:42 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
5:21 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
3:23 PM | Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
8:16 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
08/13/2024
3:17 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
12:34 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:15 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:46 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:17 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:37 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:05 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad) Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity.
New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early.
That’s why we’ve just released our latest research:
📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio” Position yourself ahead of the next move—get the full report here. |
05/30/2024
7:18 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
6:56 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4/A | |
05/30/2024
7:02 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4/A | |
05/30/2024
6:47 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4/A | |
05/30/2024
5:58 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:51 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:46 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:48 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:34 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:38 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:08 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:10 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4/A | |
05/29/2024
3:05 PM | Charles River Laboratories International (Filer)
| Form SD
Specialized Disclosure Report | |
05/28/2024
4:42 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:25 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:29 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:32 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CRL Stock Free CRL Stock Alerts